Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Migs Consulting LLC

Neither a doctor nor a teaching hospital

Research payments

$887,537

180 payments

Through program year 2025, Migs Consulting LLC is reported as receiving $887,537 in research payments, across 180 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $155,622 30
2024 Research $203,932 31
2023 Research $211,208 29
2022 Research $77,731 14
2021 Research $127,470 48
2020 Research $100,074 25
2019 Research $11,500 3

Breakdown

Who paid Research payments · program years 2019–2025
  1. AbbVie, Inc. $567,998 88 payments
  2. Allergan Inc. $244,589 68 payments
  3. Sight Sciences, Inc. $74,950 24 payments
Studies the money was for Research payments · program years 2019–2025
  1. Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma $178,328 28 payments
  2. A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension $106,494 43 payments
  3. Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension $104,439 18 payments
  4. A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension $60,888 14 payments
  5. AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension $48,977 8 payments
  6. A multicenter, open-label, single arm study in patients with open angle glaucoma or ocular hypertension who have not had previous laser trabeculoplasty treatment $45,352 4 payments
  7. Real world analysis of effectiveness of durysta sustained released glaucoma implant $41,790 1 payment
  8. Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma $31,921 5 payments
  9. A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma $26,765 6 payments
  10. Real Word Analysis of Effectiveness of Durysta Sustained Released Glaucoma Implant $23,880 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record